The following industries match your search criteria:
Published within
Click here
to sort results by relevance.
Click on heading titles to sort results by different field.
| Type |
Product title / description
|
Pub
|
Price |
Expert View
|
New research from Datamonitor has suggested that the asthma/COPD market will enjoy a 35% increase and reach a value of over $18 billion by 2011. This growth will be largely driven by the success of drug delivery technology, rather than novel drug launches. GlaxoSmithKline should therefore be the main beneficiary of this market expansion although its rivals are looking to close the gap.
Published By Datamonitor
|
24 Oct 2003 |
|
Expert View
|
Oral mucositis is a common and debilitating side effect of cancer therapies that threatens the successful treatment of 600,000 people worldwide. Inexpensive treatments can sometimes alleviate mucositis, but a truly effective treatment has yet to be launched. With Palifermin already in phase III trials, Amgen is already planning on filling this void. This outcome however, is less than certain.
Published By Datamonitor
|
19 Sep 2003 |
|
Expert View
|
Although food allergies have been recognized in the medical community since the beginning of the century, they have recently been receiving much more public attention due to the perceived increasing prevalence of the condition in the US, Europe and Japan. As new research and treatments emerge, the potential for increased profits in this under-treated area will increase dramatically.
Published By Datamonitor
|
12 Sep 2003 |
|
Expert View
|
Asthma and chronic obstructive pulmonary disease (COPD) are chronic lung disorders affecting over 80 million people in the seven major drug markets. The prevalence of asthma has risen dramatically over the last 30 years, and due to tobacco consumption in the 1970s and 1980s, COPD has also become a major problem, costing the US health system over $30 billion in medical costs in 2000.
Published By Datamonitor
|
14 Jul 2003 |
|
Expert View
|
Superficial fungal infections are found on the peripheral surfaces of the body such as the skin, hair and nails. In spite of posing no threat of mortality, these infections are very common and represent an attractive potential market. However, low presentation rates and frequent misdiagnosis mean that only a small proportion of this patient potential is currently being realized. <BR />
Published By Datamonitor
|
06 Jun 2003 |
|
Expert View
|
The considerable investment and overheads required for the development of new drugs mean that pharmaceutical companies must establish brand loyalty throughout a product's lifecycle in order to protect sales at patent expiry. While marketing has always been key to this, the advent of the Internet has meant that there are now a whole host of new opportunities for influencing market trends.<BR />
Published By Datamonitor
|
04 Apr 2003 |
|
CommentWire
|
Of the four people to have contracted the human form of mad cow disease in France so far, two have died. Both were regular customers of steakhouse chain Buffalo Grill. Allegations that the chain served British beef while it was banned in France have made headlines around Europe. The case once again highlights public concern and skepticism over food safety.
Published By Datamonitor
|
26 Feb 2003 |
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.